ABSTRACT
Introduction
Flavonoids comprise a large family of plant-derived polyphenolic compounds classified as anthocyanidins, flavonols, chalcones, aurones, flavanones, isoflavones, flavans, flavanonols, flavanols, and flavones differencing from each other in their structural group arrangements [1] . Chalcone, an important intermediate of flavonoid synthetic pathway, has been shown to exhibit diverse biological and pharmacological activities such as anticancer, antioxidant, anti-inflammatory, antimicrobial, antiallergic,and antimalarial properties [2] [3] [4] .
Oxidative damage which is implicated in various pathological events such as cancer and aging is induced by free radicals and reactive oxygen species [5] . Antioxidants are the compounds that prevent such oxidative damage due to their free radical scavenging ability [5] . In chalcones, such ability is attributable to phenolic-OH group attached to the ring structure [6] . Chalcones with antioxidant activity (and compounds with such activity in general) have been demonstrated to have anticancer, anticardiovascular, anti-inflammatory, and many other activeties [7, 8] . As such, they have gained immense interest from bioorganic and medicinal chemistry research.
Synthesized chalcones holding allylic substitutions and pyrazolicchalcones were recently reported as potent antimicrobial and antioxidant agents [9] [10] [11] [12] . In addition, the presence of enone function in chalcones having pyrazole moiety has been found to enhance the biological activity [13] .
Prompted by all these observations, we report herein the synthesis, antioxidant and antimicrobial activities of novel chalcones, pyrazolicchalcones and allylicchalcones.
Chemistry
In order to obtain pyrazolicchalcones 5a-c, the corresponding chalcones 4a-c were prepared by the ClaisenSchmidt condensation of respective acetophenones (1) and benzaldehydes (2) by the known literature method [14] . Subsequently, the corresponding pyrazolicchalcones 5a-c were prepared by the addition of the obtained chalcones 4a-c to hydrazine hydrate in absolute ethanol (Scheme 1). All of the compounds were characterized by spectral data (infrared spectroscopy [IR] and 1 
H nuclear magnetic resonance [NMR]).
The synthetic procedures and reaction conditions for allylicchalcones 11a-b are illustrated in Scheme 2. 2-Allyloxybenzaldehyde (8) was prepared by the reaction of Pyrazolic Chalcones, and Allylic Chalcones salicylaldehyde (6) and allyl bromide (7) in the presence of potassium carbonate in anhydrous acetone. Subsequently, 2-hydroxy-3-allylbenzaldehyde (9) was obtained by the Claisen thermal rearrangement [15] . The corresponding allylicchalcones 11a-b were then prepared by the Claisen-Schmidt condensation of the obtained 2-hydroxy-3-allylbenzaldehyde (9) and respective acetophenones (10) . The spectral data (IR and 1 H NMR) were used to ascertain the structures of the compounds. and Candida albicans 955 using conventional agar discdiffusion method [16] . The minimum inhibitor concentrations (MICs) were determined using micro-dilution susceptibility method [17] . Sulfamethoxazole and Ketoconazole were the reference drugs for antibacterial and antifungal testing respectively. The observed data on the antimicrobial testing are presented in Tables 1-2. zolicchalcones 5a-c and allylicchalcones 11a-b with appropriate nucleophiles using the procedures presented in Schemes 1 and 2.
Antimicrobial Activity
The results of antimicrobial testing of compounds 4/5a-c and 11a-b are presented in Tables 1-2 . The results indicated that compounds 4a-c, 5b and 11a-b did not exhibit antibacterial properties whereas compounds 5a and 5c displayed poor antibacterial activity towards Gram-positive bacteria showing inhibitor zones between 10 and 16 mm and MIC values higher than 256 μg/ml for Streptococcus faecalis and 512 μg/ml for MSSA and MRSA compared to Sulfamethoxazole. These compounds (5a and 5c), however, did not exhibit antibacterial activity against Gram-negative bacteria. None of the synthesized compounds (4/5a-c and 11a-b) showed antifungal properties.
Antioxidant Activity
The antioxidant activity of compounds 4/5a-c and 11a-b were tested using DPPH radical scavenging method [18] . Except for compounds 4a-c which failed to show such activity, all of the other test compounds (5a-c and 11a-b) exhibited good antioxidant properties, with the strongest being observed in compound 5a (Table 3) . However, all the synthesized compounds were less potent than vitamin C as the reference. The potencies for the antioxidant activity of the test compounds to the reference drug are in the following order: Vitamin C > 5a-b > 5c > 11a-b.
Conclusions
In summary, we have synthesized a series of novel chalcones, pyrazolicchalcones and allylicchalcones. We have also reported antimicrobial and antioxidant evaluations of these compounds. All the synthesized compounds showed poor antimicrobial properties or did not show such properties. A good antioxidant activity was observed in pyrazolicchalcones and allylicchalcones.
Experimental

Chemistry
All chemicals were purchased from commercial suppliers, and used without further purification. All solvents used for reaction were freshly distilled from proper dehydrateing agents. Melting points were determined in open capillaries on a Gallenkamp Melting Point Apparatus and are uncorrected. The purity of the compounds was checked by thin layer chromatography (TLC) (silica gel H, n-hexaneacetone 3:1). The IR spectra were performed on a Shimadzu FTIR 8101 spectrometer in potassium bromide (KBr) pellets and the wave numbers were given in cm 1 mol) , potassium carbonate (0.3 mol) and dimethyl sulphate (0.09 mol) in 20 ml anhydrous acetone were refluxed for 4 hours, monitoring by TLC with solvent system of n-hexane-acetone (3:1). After removing potassium carbonate, the reaction solution was evaporated in vacuo, giving solid. The solid was filtered, washed with water, dried, and crystalized from methanol to yield 2-hydroxy-4-methoxyacetophe0 none as gray solid with overall yield of 81%. This product was used as the material for the synthesis of 4a.
2'-Hydroxy-3,4,4'-trimethoxychalcone (4a)
2-Hydroxy-4-methoxyacetophenone (1.05 equivalence) and 3,4-dimethoxybenzaldehyde were dissolved in methanol. To the above mixture, potassium hydroxide (3 equivalence) was added in portions to give a blood-red solution. The reaction mixture was stirred at room temperature for 32 hours, during which 2'-hydroxy-3,4,4'-trimethoxychalcone (4a) precipitated as the potassium salt. The reaction mixture was poured into cold 1N hydrochloride acid (HCl) solution and was further added concentrated HCl (c-HCl) until the solution became acidic. The resulting precipitate was filtered, washed with water, and crystalized from methanol to give product 4a as crystals. 
4'-Nitro-4-dimethylaminochalcone (4b)
4-Nitroacetophenone (1.05 equivalence) and 4-dimethylaminobenzaldehyde were dissolved in methanol. To the above mixture, potassium hydroxide (3 equivalence) was added in portions to give a blood-red solution. The reaction mixture was stirred at room temperature for 32 hours, during which 4'-nitro-4-dimethylaminochalcone (4b) precipitated as the potassium salt. The reaction mixture was poured into cold 1N-HCl solution and was further added c-HCl until the solution became acidic. The resulting precipitate was filtered, washed with water, and crystalized from methanol to give product 4b as crystals. Yield 79%. Light yellow solid, mp: 206˚C, IR (KBr), ν (cm 
2-(5-(3,4-Dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl)-5-methoxyphenol (5a)
2'-Hydroxy-3,4,4'-trimethoxychalcone (4a, 2 mmol) was dissolved in 100 ml absolute ethanol. To this mixture, hydrazine hydrate (4 mmol) was added dropwise at room temperature. The reaction mixture was refluxed for 7 hours, monitoring by TLC with solvent system of nhexane-acetone (3:1). The reaction mixture was cooled in ice bath. The resulting white solid was filtered and washed with cold water. The filtrate was extracted with ether and evaporated in vacuo yielding more solid. The solid was collected and crystalized from ethanol to yield 2-(5- 
N,N-Dimethyl-4-(3-(4-nitrophenyl)-4,5-dihydro-1H-pyrazol-5-yl)-benzenamin (5b)
4'-Nitro-4-dimethylaminochalcone (4b, 2 mmol) was dissolved in 100 ml absolute ethanol. To this mixture, hydrazine hydrate (4 mmol) was added dropwise at room temperature. The reaction mixture was refluxed for 7 hours, monitoring by TLC with solvent system of n-hexaneacetone (3:1). The reaction mixture was cooled in ice bath. The resulting white solid was filtered and washed with cold water. The filtrate was extracted with ether and evaporated in vacuo yielding more solid. The solid was collected and crystalized from ethanol to yield N,N-di- 
2-Allyloxybenzaldehyde (8)
To a solution of salicylaldehyde (6, 0.1 mol) and allyl bromide (7, 0.11 mol) in anhydrous acetone (30 ml), potassium carbonate (0.12 mol) was added. The reaction mixture was refluxed for 3 hours. At the completion of the reaction (monitoring by TLC with solvent system of n-hexane-acetone 3:1), the resulting mixture was cooled to room temperature and poured into water (150 ml). The aqueous phase was then extracted with dichloromethane. The obtained extract was washed with 5% sodium hydroxide (NaOH) solution and water. The organic phase was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. After distillation under reduced pressure, 2-allyloxybenzaldehyde (8) was obtained as a yellow liquid. Yield 87%, boiling point (bp): 273.5˚C/760 mmHg.
sorption maximum at λ 517 nm, which is purple in color [18] . A radical scavenging antioxidant reacts with DPPH stable free radical, resulting in the decolorization which is stoichiometric with respect to the number of electrons captured [18] . The change on the absorbance produced in this reaction is used to measure antioxidant properties [18] .
Stock solutions of different compounds (1 mM) were mixed with 0.5 ml of 0.3 mMDPPH in methanol. Final volume was adjusted to 3 ml. Reaction mixtures were variously shaken and allowed to react for 30 minutes in the dark at room temperature. Absorbance values were measured at 517 nm using anultraviolet-visible (UV-VIS) spectrophotometer. 0.5 ml of 0.3 mM DPPH diluted in 2.5 ml of methanol was used as control. Absorbance was converted to % antioxidant activity using the following equation: S (%) = 100 (A 0 -A S )/A 0 where A 0 is the absorbance of the control (containing all reagents except the test compound) and A S represents absorbance of the test compound. Results were compared with activity of vitamin C which was used as the standard. The data are summarized in Table 3 .
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